|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.00 GBX | +2.56% |
|
-4.76% | -36.51% |
| 07-02 | SkinBioTherapeutics plc Announces Termination of Emily Lorraine Bertram as Director, Effective June 30, 2026 | CI |
| 07-02 | SkinBioTherapeutics plc - Shareholder/Analyst Call |
| Market Cap | 25.92M 34.87M 30.47M 28.14M 48.88M 3.36B 49.94M 336M 132M 1.64B 131M 128M 5.66B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 29.45M 39.63M 34.63M 31.98M 55.56M 3.81B 56.75M 382M 150M 1.87B 149M 146M 6.44B | EV / Sales 2026 * |
4.75x | EV / Sales 2027 * | 3.6x |
| Free-Float |
61.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SkinBioTherapeutics plc
| 1 day | +2.56% | ||
| 1 week | -4.76% | ||
| Current month | -4.76% | ||
| 1 month | -13.04% | ||
| 3 months | +2.56% | ||
| 6 months | -48.39% | ||
| Current year | -36.51% |
| 1 week | 9.5 |  | 10.37 |
| 1 month | 9.5 | | 13.32 |
| Current year | 5 | | 23 |
| 1 year | 5 | | 23 |
| 3 years | 5 | | 29.5 |
| 5 years | 5 | | 78.25 |
| 10 years | 5 | | 88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rachel Parsonage
CEO | Chief Executive Officer | - | 01/03/2026 |
| Comptroller/Controller/Auditor | - | 28/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 28/02/2017 | |
Alyson Levett
CHM | Chairman | 60 | - |
Rachel Parsonage
BRD | Director/Board Member | - | 08/03/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/04/23 | Buy | Chief Executive Officer | 122,517 | 0.0708% | ||
| 14/04/23 | Sell | Chief Executive Officer | 123,878 | 0.0715% | ||
| 09/03/23 | Sell | Chief Financial Officer | 89,472 | 0.0517% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.56% | -4.76% | -39.39% | -17.53% | 34.07M | |
| -7.17% | -2.63% | +49.59% | +74.24% | 55.98B | |
| +0.24% | -5.62% | +54.73% | +125.15% | 53.69B | |
| +0.80% | -8.41% | +3.57% | +425.83% | 23.29B | |
| -0.09% | -1.61% | -18.68% | -15.48% | 23.15B | |
| -5.95% | -0.22% | +35.96% | -9.58% | 20.58B | |
| -1.14% | -3.16% | +32.88% | -28.80% | 17.76B | |
| -5.16% | -7.00% | +177.56% | +326.39% | 16.09B | |
| -6.91% | +2.40% | +36.86% | +636.97% | 15.93B | |
| +0.43% | -2.07% | +24.79% | +188.40% | 14B | |
| Average | -2.24% | -1.84% | +35.79% | +170.56% | 24.05B | |
| Weighted average by Cap. | -2.92% | -2.20% | +43.57% | +157.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.2M 8.34M 7.29M 6.73M 11.69M 803M 11.95M 80.45M 31.61M 393M 31.3M 30.63M 1.35B | 8.2M 11.03M 9.64M 8.9M 15.47M 1.06B 15.8M 106M 41.81M 520M 41.4M 40.52M 1.79B |
| Net income | - | - |
| Net Debt | 3.54M 4.76M 4.16M 3.84M 6.67M 458M 6.82M 45.91M 18.04M 224M 17.86M 17.48M 773M | 3.57M 4.8M 4.2M 3.88M 6.73M 462M 6.88M 46.33M 18.2M 226M 18.02M 17.64M 780M |
Employees
41
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | GBX 10.00 | +2.56% | 281,940 |
| 16/07/26 | GBX 9.750 | 0.00% | 169,694 |
| 15/07/26 | GBX 9.750 | 0.00% | 1,044,266 |
| 14/07/26 | GBX 9.750 | 0.00% | 39,089 |
| 13/07/26 | GBX 9.750 | -4.88% | 333,702 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1000GBP
Average target price
0.2900GBP
Spread / Average Target
+190.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition